In contrast to MSC inhibiting tumor progression and similar to what is described within this paper, our previous data shows that MSC can enhance the growth rate of a subpopulation of breast cancer cells in vitro and in vivo through paracrine interleukin-6 (IL-6) signaling events [38], [39]. The gene discussed is IL6; the disease is neoplasm.